Cargando…

One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein

The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for signi...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kalyoubi, Samar A., Ragab, Ahmed, Abu Ali, Ola A., Ammar, Yousry A., Seadawy, Mohamed G., Ahmed, Aya, Fayed, Eman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954694/
https://www.ncbi.nlm.nih.gov/pubmed/35337173
http://dx.doi.org/10.3390/ph15030376
_version_ 1784676156931309568
author El-Kalyoubi, Samar A.
Ragab, Ahmed
Abu Ali, Ola A.
Ammar, Yousry A.
Seadawy, Mohamed G.
Ahmed, Aya
Fayed, Eman A.
author_facet El-Kalyoubi, Samar A.
Ragab, Ahmed
Abu Ali, Ola A.
Ammar, Yousry A.
Seadawy, Mohamed G.
Ahmed, Aya
Fayed, Eman A.
author_sort El-Kalyoubi, Samar A.
collection PubMed
description The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for significant effectiveness in the clinical treatment of COVID-19 patients, despite the worsening trends of COVID-19. This study aims to design a simple and efficient cyclo-condensation reaction of 6-aminouracil derivatives 2a–e and isatin derivatives 1a–c to synthesize spiro-oxindoles 3a–d, 4a–e, and 5a–e. All compounds were tested in vitro against the SARS-CoV-2. Four spiro[indoline-3,5′-pyrido[2,3-d:6,5-d’]dipyrimidine derivatives 3a, 4b, 4d, and 4e showed high activities against the SARS-CoV-2 in plaque reduction assay and were subjected to further RNA-dependent-RNA-polymerase (RdRp) and spike glycoprotein inhibition assay investigations. The four compounds exhibited potent inhibitory activity ranging from 40.23 ± 0.09 to 44.90 ± 0.08 nM and 40.27 ± 0.17 to 44.83 ± 0.16 nM, respectively, when compared with chloroquine as a reference standard, which showed 45 ± 0.02 and 45 ± 0.06 nM against RdRp and spike glycoprotein, respectively. The computational study involving the docking studies of the binding mode inside two proteins ((RdRp) (PDB: 6m71), and (SGp) (PDB: 6VXX)) and geometrical optimization used to generate some molecular parameters were performed for the most active hybrids.
format Online
Article
Text
id pubmed-8954694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89546942022-03-26 One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein El-Kalyoubi, Samar A. Ragab, Ahmed Abu Ali, Ola A. Ammar, Yousry A. Seadawy, Mohamed G. Ahmed, Aya Fayed, Eman A. Pharmaceuticals (Basel) Article The first outbreak in Wuhan, China, in December 2019 was reported about severe acute coronaviral syndrome 2 (SARS-CoV-2). The global coronavirus disease 2019 (COVID-19) pandemic in 2020 resulted in an extremely high potential for dissemination. No drugs are validated in large-scale studies for significant effectiveness in the clinical treatment of COVID-19 patients, despite the worsening trends of COVID-19. This study aims to design a simple and efficient cyclo-condensation reaction of 6-aminouracil derivatives 2a–e and isatin derivatives 1a–c to synthesize spiro-oxindoles 3a–d, 4a–e, and 5a–e. All compounds were tested in vitro against the SARS-CoV-2. Four spiro[indoline-3,5′-pyrido[2,3-d:6,5-d’]dipyrimidine derivatives 3a, 4b, 4d, and 4e showed high activities against the SARS-CoV-2 in plaque reduction assay and were subjected to further RNA-dependent-RNA-polymerase (RdRp) and spike glycoprotein inhibition assay investigations. The four compounds exhibited potent inhibitory activity ranging from 40.23 ± 0.09 to 44.90 ± 0.08 nM and 40.27 ± 0.17 to 44.83 ± 0.16 nM, respectively, when compared with chloroquine as a reference standard, which showed 45 ± 0.02 and 45 ± 0.06 nM against RdRp and spike glycoprotein, respectively. The computational study involving the docking studies of the binding mode inside two proteins ((RdRp) (PDB: 6m71), and (SGp) (PDB: 6VXX)) and geometrical optimization used to generate some molecular parameters were performed for the most active hybrids. MDPI 2022-03-20 /pmc/articles/PMC8954694/ /pubmed/35337173 http://dx.doi.org/10.3390/ph15030376 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
El-Kalyoubi, Samar A.
Ragab, Ahmed
Abu Ali, Ola A.
Ammar, Yousry A.
Seadawy, Mohamed G.
Ahmed, Aya
Fayed, Eman A.
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title_full One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title_fullStr One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title_full_unstemmed One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title_short One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
title_sort one-pot synthesis and molecular modeling studies of new bioactive spiro-oxindoles based on uracil derivatives as sars-cov-2 inhibitors targeting rna polymerase and spike glycoprotein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954694/
https://www.ncbi.nlm.nih.gov/pubmed/35337173
http://dx.doi.org/10.3390/ph15030376
work_keys_str_mv AT elkalyoubisamara onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT ragabahmed onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT abualiolaa onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT ammaryousrya onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT seadawymohamedg onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT ahmedaya onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein
AT fayedemana onepotsynthesisandmolecularmodelingstudiesofnewbioactivespirooxindolesbasedonuracilderivativesassarscov2inhibitorstargetingrnapolymeraseandspikeglycoprotein